Innovative Healthcare Technology: The FreeStyle Libre 14 Day System by Brittany Ferguson BSN, RN-BC https://padlet.com/brittany_ferguson24/FreeStyleLibre14 Advancement in Glucose Monitoring for Diabetes Management. UT Tyler NURS 5324. en-us 2019-09-25 22:26:53 UTC 2024-11-05 20:27:00 UTC hello@padlet.com https://padlet.pics/1/image.webp?t=g_auto&url=https%3A%2F%2Fpadlet.net%2Ficons%2Fpng%2F1f98b.png Quick Video Overview brittany_ferguson24 https://padlet.com/brittany_ferguson24/FreeStyleLibre14/wish/389770528 2019-09-25 22:39:30 UTC https://padlet.com/brittany_ferguson24/FreeStyleLibre14/wish/389770528 Source Details brittany_ferguson24 https://padlet.com/brittany_ferguson24/FreeStyleLibre14/wish/389770805 IMPACT Randomized Control Trial (RCT)

Authors with Departments of Medicine and Diabetes
Type 1 Diabetics and CGM effect on hypoglycemic episodes

Reference
Oskarsson, P., Antuna, R., Geelhoed-Duijvestijn, P., Krӧger, J., Weitgasser, R., & Bolinder, J. (2018). Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: A pre-specified subgroup analysis of the IMPACT randomised controlled trial. Diabetologia, 61(3), 539-550.

REPLACEMENT RCT

Authors are with Different universities in Department of Endocrinology and Diabetes
Study on Type 2 Diabetes that required insulin treatment

Reference
Haak, T., Hanaire, H., Ajjan, R., Hermanns, N., Riveline, J., & Rayman, G. (2017). Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes. Diabetes Therapy, 8(3), 573-586. doi: 10.1007/s13300-017-0255-6

Interview with Abbott

Interviewer: Conn Hastings, PhD from the Royal College of Surgeons and became a full-time science writer and editor.
Interviewee: Chris Thomas is the Director for Biosensing Technology at Abbott.
Article published on Sept. 20, 2019 to Medgadget a credible source for reporting the latest in medical technologies.
Bias may be seen with Abbott promotion of product, but RCT's regarding the impact and replacement were cited.

Reference

Hastings, C. (2019). FreeStyle Libre 14 day System: Interview with Chris Thomas, Director of Biosensing Technology, Abbott. Exclusive Medicine. Retrieved from Medgadget.com

]]> 2019-09-25 22:40:49 UTC https://padlet.com/brittany_ferguson24/FreeStyleLibre14/wish/389770805 What is the FreeStyle Libre? brittany_ferguson24 https://padlet.com/brittany_ferguson24/FreeStyleLibre14/wish/389775125

14 day Continuous Glucose Monitor (CGM)

Wearable system that is placed on the back of the upper arm (size of two quarters)

CGM readings are taken from the interstitial fluid using a 0.4 mm sensor filament

Wearer holds smart phone or provided meter up to the sensor and glucose value is displayed painlessly

Data is automatically uploaded to the app and can be trended

Approved for use by the US FDA in September of 2017

(Hastings, 2019)

]]> 2019-09-25 23:03:30 UTC https://padlet.com/brittany_ferguson24/FreeStyleLibre14/wish/389775125 Product Web Link brittany_ferguson24 https://padlet.com/brittany_ferguson24/FreeStyleLibre14/wish/389775359 2019-09-25 23:04:54 UTC https://padlet.com/brittany_ferguson24/FreeStyleLibre14/wish/389775359 Pros brittany_ferguson24 https://padlet.com/brittany_ferguson24/FreeStyleLibre14/wish/389775521

Smallest and longest lasting self-applied sensor available

Moves away from the traditional finger-stick method of blood glucose monitoring

Less painful and less invasive

Can be used with smart phone or purchased meter

Scanning for glucose is painless and application is minimally painful

Allows for monitoring of trends of glucose measurements

Provides information within one to three seconds

Waterproof

Improved compliance with health plan of care

More data for clinician assessment can be shared via different methods

Previous monitors required bulkier equipment

Low cost compared to other CGMs

Decreases fear and anxiety of hypo and hyperglycemia

]]> 2019-09-25 23:06:07 UTC https://padlet.com/brittany_ferguson24/FreeStyleLibre14/wish/389775521 Cons brittany_ferguson24 https://padlet.com/brittany_ferguson24/FreeStyleLibre14/wish/389775540

Requires a device that is worn on the body

Only site allowed is the back of the upper arm

Could potentially be inaccurate or defective, requiring finger stick

Does not have any alarms or alerts

Interstitial glucose readings can be about five to ten minutes behind blood glucose readings

Risk of allergic skin reaction

Not integrated with insulin pumps (pump still require programming for bolus insulin dose or stop basal rate)

May not be fully covered under insurance

Each CGM can cost between $35 to 100 (lasting 14 days), which can be more expensive than blood glucose finger-stick

May lose adhesiveness and come off

Contraindicated during MRI, CT, X-ray, or diathermy

Not approved for pregnant women, people receiving dialysis, critically ill, or children (younger than 18)

]]> 2019-09-25 23:06:14 UTC https://padlet.com/brittany_ferguson24/FreeStyleLibre14/wish/389775540 Discussion brittany_ferguson24 https://padlet.com/brittany_ferguson24/FreeStyleLibre14/wish/389775903 More than 425 million people live with diabetes around the world. This innovative technology makes diabetes more manageable. People with diabetes may have comorbidities that require multiple treatments, by simplifying diabetes treatment, compliance and health can improve. According to studies, this is a safe and beneficial alternative to traditional methods.
Type 1 Diabetes
Oskarsson, et al., (2018) reported markedly reduced hypoglycemic events, including during the nighttime hours. A con with this system is that it is not approved for the high prevalence population of children. More research should be done to make this safe for children.
The CGM should be integrated with insulin pumps. According to Hastings (2019), partnerships with other companies are being forged to make these products integrative.
Type 2 Diabetes
Haak, et al., (2017) reported sustained significant reduction of blood glucose and hemoglobin A1C, and a safe and effective replacement for finger-stick blood glucose monitoring for all ages.
Overall
Patients in both studies scanned sensors 13 to 18 times per day. Compliance with blood glucose monitoring is much higher compared to traditional methods of finger stick. More continuous data can allow for better intervention and management of diabetes. Both studies show that is a safe and effective alternative to traditional methods for patients with diabetes. ]]> 2019-09-25 23:08:10 UTC https://padlet.com/brittany_ferguson24/FreeStyleLibre14/wish/389775903 Innovation Implementation Team brittany_ferguson24 https://padlet.com/brittany_ferguson24/FreeStyleLibre14/wish/389826801

My top 5 Strengths include: Achiever, Learner, Positivity, Strategic, Relator

I take satisfaction from feeling productive, I have a strong work ethic and I have the will and desire to learn

Faith: Futuristic

Inspirational
Creative ideas for the future

Fernando: Focus

Able to take direction
Able to prioritize and follow through

Abraham: Analytical

Ability to see all factors that influence a situation

Pablo: Positivity

Brings encouragement and energy to the team

Sheila: Strategic

Good judgement to recognize patterns
Assist with decision making

I chose this group because the strengths meld together to create a diverse and cohesive team. When implementing the CGM into a healthcare facility multiple factors must be considered. I can guide the team to create objectives, and work through the problems and cons of the system. I can consult with Sheila and Abraham on the plan to introduce and implement the product to discuss potential influencing factors. I can count on Fernando to take direction and help prioritize what is most important in order to complete the project. Pablo will help encourage the team through struggles, and Faith will be there when we have run out of ideas and we need a creative mind for planning.

]]> 2019-09-26 02:50:41 UTC https://padlet.com/brittany_ferguson24/FreeStyleLibre14/wish/389826801